Beyond the cerebrospinal fluid: Preclinical and clinical evidence on central nervous system penetration and functional activity of oral rapamycin (sirolimus)

Jeffrey M. Melin, Nancy A. Young, Joseph Camardo

Open source

DOI
10.1177/13872877261495936
Published
2026-10-09
Container
Journal of Alzheimer’s Disease
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/13872877261495936,
  title = {Beyond the cerebrospinal fluid: Preclinical and clinical evidence on central nervous system penetration and functional activity of oral rapamycin (sirolimus)},
  author = {Jeffrey M. Melin and Nancy A. Young and Joseph Camardo},
  year = {2026},
  journal = {Journal of Alzheimer’s Disease},
  doi = {10.1177/13872877261495936},
  url = {https://doi.org/10.1177/13872877261495936}
}

RIS

TY  - JOUR
TI  - Beyond the cerebrospinal fluid: Preclinical and clinical evidence on central nervous system penetration and functional activity of oral rapamycin (sirolimus)
AU  - Jeffrey M. Melin
AU  - Nancy A. Young
AU  - Joseph Camardo
PY  - 2026
JO  - Journal of Alzheimer’s Disease
DO  - 10.1177/13872877261495936
UR  - https://doi.org/10.1177/13872877261495936
ER  - 

APA

Melin, J. M., Young, N. A., & Camardo, J. (2026). Beyond the cerebrospinal fluid: Preclinical and clinical evidence on central nervous system penetration and functional activity of oral rapamycin (sirolimus). Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877261495936

Source records